08045479576
08045479576
Oxybutynin HCI
26000 INR/Kilograms
Product Details:
- Structural Formula C22H31NO3.HCl
- Molecular Weight 357.5 Grams (g)
- Loss on Drying 731
- Melting Point 125-130 C
- Solubility soluble in acids but insoluble in alkalis
- EINECS No 216-139-7
- Boiling point 494.4 C at 760 mmHg
- Click to View more
-
Share Your Product:
X
Oxybutynin HCI Price And Quantity
- 24000.00 - 30000.00 INR/Kilograms
- 25 Kilograms
- 26000 INR/Kilograms
Oxybutynin HCI Product Specifications
- Other
- Benzeneaceticacid, a-cyclohexyl-a-hydroxy-,4-(diethylamino)-2-butynyl ester (9CI);Cyclohexaneglycolic acid, a-phenyl-,4-(diethylamino)-2-butynyl ester (8CI);2-Butyn-1-ol, 4-(diethylamino)-, a-phenylcyclohexaneglycolate(ester) (8CI);(RS)-Oxybutynin;4-Diethylamino-2-butynyl a-phenylcyclohexaneglycolate;Ditropan;Ditropan XL;Kentera;Oxybutynin;Oxytrol;Uromax;
- C22H31NO3.HCl
- 5633-20-5
- soluble in acids but insoluble in alkalis
- 216-139-7
- Oxybutynin is used to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in certain adults and children.
- 494.4 C at 760 mmHg
- Powder
- Medicine Grade
- No Smell
- C22H31NO3.HCl
- Benzeneaceticacid, a-cyclohexyl-a-hydroxy-,4-(diethylamino)-2-butynyl ester (9CI);Cyclohexaneglycolic acid, a-phenyl-,4-(diethylamino)-2-butynyl ester (8CI);2-Butyn-1-ol, 4-(diethylamino)-, a-phenylcyclohexaneglycolate(ester) (8CI);(RS)-Oxybutynin;4-Diethylamino-2-butynyl a-phenylcyclohexaneglycolate;Ditropan;Ditropan XL;Kentera;Oxybutynin;Oxytrol;Uromax;
- 357.5 Grams (g)
- 731
- 29420090
- Pharmaceutical Intermediates
- 125-130 C
- Room Temperature
- white to off-white crystalline powder
Oxybutynin HCI Trade Information
- mumbai india
- Letter of Credit (L/C) Delivery Point (DP) Letter of Credit at Sight (Sight L/C) Cash Against Delivery (CAD) Days after Acceptance (DA)
- 25 Kilograms Per Week
- 1 Week
- Free samples are available
- DRUM
- Australia North America South America Eastern Europe Western Europe Middle East Africa Central America Asia
- ISO GMP
Product Description
Â
Oxybutynin HCI produced at our Gujarat based facility following all the regulations is pure and effective. This tertiary amine has antimuscarinic and antispasmodic properties. By blocking the muscarinic receptors in smooth muscle, oxybutynin suppresses the binding of acetylcholine and reduces the activity of involuntary muscles. The compound oxybutynin reduces bladder contractions by relaxing bladder smooth muscle. As an anticholinergic, oxybutynin is used for treating urinary incontinence and overactive bladder.
Technical Specifications :
- CAS No: 1508-65-2
- Synonyms: Ditropan, Oxytrol, Oxibutyninum
- Molecular Formula: C22H31NO3
- Molecular Weight: 357.5
- Melting point: 126-128 deg C
- Boiling point: 494.4 deg CÂ
- Storage condition: Room tem
How does it work:
Spasms in the bladder muscle are prevented which can reduce the symptoms of urinary incontinence or the sensation of urgency that can lead to bladder spasms. Additionally, Oxybutynin hydrochloride may be beneficial in treating bedwetting in children.
Â
Certain adults and children are treated with Oxybutynin when they have overactive bladders.
Applications Or where it is used:
Â
Overactive bladder is treated with oxybutynin in children and adults. The extended-release tablet form of Oxybutynin is also used to control bladder muscles in adults and children with spina bifida or other disorders of the nervous system that affect the bladder muscles. An anticholinergic/antimuscarinic is an oxybutynin. The bladder muscles are relaxed when it is taken.
Manufacturing process:
Â
The components are mixed in the ascending order of weights in polybag for ten minutes to ensure uniform blending and finally magnesium stearate (lubricant) and talc (glidant) are added after proper mixing. RIMEKs rotary tablet punching machine uses an 8 mm round punch for direct compression of the powder mixture.
How to use:
Â
Oxybutynin comes in tablet, syrup, and extended-release (long-acting) tablet forms. This should be taken twice daily, once in the morning and once in the evening. Every day, take oxybutynin around the same time(s). Read your prescription label carefully, and ask your pharmacist or doctor for an explanation if you do not understand a part. You can take Oxybutynin either with food or without food.
Dosage of usage:
- Immediate Release Tablets/Syrup:
- Initial dose: 5 mg orally 2 to 3 times a day
- Maximum dose: 5 mg orally 4 times a day
Side effects :
The common side effects of Oxybutynin are being unable to urinate, drowsiness, sweating less than usual, dry mouth, blurry vision, dizziness and trouble sleeping.
Warnings and precautions while using this product:
In case of untreated or uncontrolled narrow-angle glaucoma, blockages in your digestive tract, or difficulty urinating, I would not use oxybutynin. Before using oxybutynin, the patient must inform their doctor if they have liver or kidney disease, glaucoma, an enlarged prostate, ulcerative colitis, myasthenia gravis, a blockage in stomach or intestines, or a stomach disorder. Stay hydrated and avoid overheating or dehydration when exercising in a hot environment. Oxybutynin may decrease perspiration, which can lead to heat strokes. Your vision may be blurred and your thinking or reaction could be impaired by this medication. You should be careful while driving or doing anything that requires alertness and clear vision.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
+91
Email
Other Products in 'Active Pharmaceuticals Ingredients (API)' category
Contact Us
- 311, Atlantis Heights, Sarabhai Main Road, Vadiwadi,Vadodara - 390007, Gujarat, India
- Phone :08045479576
-
Send Inquiry
Mr. Nilesh Bansilal Sheth (Partner)
Mobile :08037400111
: nilesh.sheth70
MR. Tushar V. Kavade (Partner) : tushar.kavade
Send Inquiry
|
SHREEJI PHARMA INTERNATIONAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
